<?xml version="1.0" encoding="UTF-8"?>
<p>A3: Synthesis of (
 <italic>E</italic>)-3-(1″H-indol-3″-yl)-1-[4′-(trifluoromethyl)phenyl]prop-2-en-1-one: Yield: 50%; m.p. 62 °C; R
 <italic>
  <sub>f</sub>
 </italic> = 0.9 (30% Ethyl acetate in Hexane); FT-IR (KBr, cm
 <sup>−1</sup>): 1695 (C=O), 1611 (C=C Ar), 1573 (CH=CH), 1263 (-CF
 <sub>3</sub>), 3010 (Ar C-H stretching), 3230 (-NH); 
 <sup>1</sup>H NMR (400 MHz, CDCl
 <sub>3</sub>, ppm): 
 <italic>δ</italic>: 7.77 (1H, d, 
 <italic>J</italic> = 16.3 Hz, -CO-CH=), 8.13 (1H, d, 
 <italic>J</italic> = 15.9 Hz, Ar-CH=), 8.78 (1H, s, -NH), 7.94-8.14 (4H, m, C-2′, 3′, 5′, 6′, Ar-H), 7.05-7.61 (5H, m, C-2″, 4″, 5″, 6″, 7″, Ar-H); 
 <sup>13</sup>C NMR (125 MHz, CDCl3, ppm): 189.93 (C-1), 128.60 (C-2), 142.02 (C-3), 140.11 (C-1′), 128.60 (C-2′ and 6′), 125.59 (C-3′ and 5′), 137.30 (C-4′), 123.77 (C-4,′), 129.52 (C-6′), 112.06 (C-1″), 125.30 (C-2″), 130.30 (C-4″), 114.06 (C-5″), 120.71 (C-6″), 122.02 (C-7″), 117.44 (C-8″), 125.56 (C-9″); ESI-MS: 316.30 [M + H]
 <sup>+</sup>; 
 <sup>19</sup>F NMR (376 MHz, CDCl
 <sub>3</sub>): δ: 63.27 (3F, s).
</p>
